Novel Diagnostic Method For Diagnosing Depression And Monitoring Therapy Effectiveness


The present invention relates to a method of diagnosing or monitoring the progression of a mood disorder, by assaying the level of lipocalin-2 in the body fluid of a subject. Preferably said mood disorder is depression, chosen from dysthymia, endogenous depression, minor depression, major depression, psychotic depression, neurotic depression, postnatal depression, burn out, overstrain, unipolar depression and bipolar depression. Also a combined detection of lipocalin-2 and BDNF for the method according to the invention is proposed.

Download PDF
Document Preview
Document History
  • Publication: Jan 17, 2013
  • Application: Jul 13, 2012
    WO NL 2012050505 W
  • Priority: Jul 14, 2011
    US US 201161507869 P
  • Priority: Jul 14, 2011
    NL NL 2007112 A

Download Citation

Sign in to the Lens